Analysis of the Curative Effect and Prognosis of 32 Cases of Drug Resistant Tuberculosis Meningitis_West China Medical Journal

Authors：

 DengQian ,  LaiXiaohui

Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

LaiXiaohui, Email: lxhneu@aliyun.com

Keywords：

Tuberculous meningitis; Drug resistance; Curative effect; Prognosis

DOI：

10.7507/1002-0179.20160058

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analyze the curative effect and prognosis of drug resistant tuberculosis meningitis (TBM). Methods Retrospective analysis was carried out on the clinical data of thirty-two cases of drug resistant tuberculous meningitis patients hospitalized from January 2010 to December 2015. And the prognosis of the patients was evaluated by meliorated Rankin Scale (mRS). Results Thirty-one cases (96.9%) were improved in 32 patients with drug resistant TBM, and 1 case (3.1%) was ineffective. After treatment, one patient had hormone-related glaucoma and osteoporosis, and one patient had drug Cushing syndrome. Twenty-seven patients (84.4%) had an mRS score equal to or less than 2 points. Conclusion Drug resistant TBM is difficult to diagnose in the early stage, and the curative effect is satisfying with active anti-tuberculosis treatment.

Citation： DengQian, LaiXiaohui. Analysis of the Curative Effect and Prognosis of 32 Cases of Drug Resistant Tuberculosis Meningitis. West China Medical Journal, 2016, 31(2): 208-211. doi: 10.7507/1002-0179.20160058 Copy

1.	World Health Organization. Global tuberculosis control:surveillance, planning, financing. WHO report WHO/HTM/TB/2007.376[R]. Geneva:World Health Organization, 2007.
2.	Zumla A, Raviglione M, Hafner R, et al. Tuberculosis[J]. N Engl J Med, 2013, 368(8):745-755.
3.	Liao PW, Chiang TR, Lee MC, et al. Tuberculosis with meningitis, myeloradiculitis, arachnoiditis and hydrocephalus:a case report[J]. Acta Neurol Taiwan, 2010, 19(3):189-193.
4.	Lienhardt C, Fielding K, Sillah JS, et al. Investigation of the risk factors for tuberculosis:a case-control study in three countries in West Africa[J]. Int J Epidemiol, 2005, 34(4):914-923.
5.	Lienhardt C, Bennett S, Del Prete G, et al. Investigation of environmental and host-related risk factors for tuberculosis in Africa. I. Methodological aspects of a combined design[J]. Am J Epidemiol, 2002, 155(11):1066-1073.
6.	Wright A. Anti-tuberculosis drug resistance in the world. Fourth Global Report:the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance[M]. 4th ed. Geneva:World Health Organization, 2008.
7.	閆世明, 孫秀娟, 鄒志艷, 等. 不同劑量地塞米松治療結核性腦膜炎的對比觀察[J]. 中華結核和呼吸雜志, 1995, 18(4):236.
8.	劉風霞, 劉雪云, 戰云飛. 結核性腦膜炎96例臨床分析[J]. 臨床肺科雜志, 2012, 17(3):471-472.
9.	中華醫學會. 臨床診療指南結核病學分冊[M]. 北京:人民衛生出版社, 2009:58-61.
10.	劉建民, 關玲, 侯紅革, 等. 結核性腦膜炎120例臨床分析[J]. 中國實用神經疾病雜志, 2012, 15(20):66-67.
11.	孫沖, 徐迪榮, 李碧磊. 改良Rankin量表在急性大面積腦梗死長期生存的預后價值[J]. 醫學研究雜志, 2012, 41(12):179-182.
12.	World Health Organization. Global tuberculosis control 2009:epidemiology strategy financing[M]. http://reliefweb.int/sites/reliefweb.int/files/resources/878BDA5E2504C9F449257584001B5E60-who_mar2009.pdf.
13.	王黎霞. 中國耐多藥結核病的控制亟待加強[J]. 中華結核和呼吸雜志, 2009, 32(8):561-563.
14.	馬玙, 朱莉貞, 潘毓萱. 結核病[M]. 北京:人民衛生出版社, 2006:254-262.
15.	Mizutani T, Kurosawa N, Matsuno Y, et al. A typical manifestation of tubeiculous meninpitis[J]. Eur Nenrol, 1993, 33(2):159-162.
16.	趙鋼, 杜芳. 結核性腦膜炎臨床診斷思路[J]. 中國現代神經疾病雜志, 2013, 13(1):1-4.
17.	張艷虹. 高原地區兒童結核性腦膜炎臨床特征及早期診斷探討[J]. 醫學綜述, 2011, 17(16):2552-2553.
18.	王郁. 結核性腦膜炎臨床診斷與治療分析——附48例報道[J]. 中國醫藥指南, 2011, 9(26):64-65.
19.	Panicker JN, Nagaraja D, Subbakrishna DK, et al. Role of the BACTEC radiometric method in the evaluation of patients with clinically probable tuberculous meningitis[J]. Ann Indian Acad Neurol, 2010, 13(2):128-131.
20.	葉叔文, 王明杰, 鄒建勛, 等. 腦結核的CT及MR診斷[J]. 浙江中西醫結合雜志, 2012, 22(1):51-53.
21.	Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis[J]. Cochrane Database Syst Rev, 2008(1):CD002244.
22.	Sinner SW, Tunkel AR. Approach to the diagnosis and management of tuberculous meningitis[J]. Curr Infect Dis Rep, 2002, 4(4):324-331.
23.	張魯軍, 劉麗, 趙巧華. 35例結核性腦膜炎臨床死亡原因分析[J]. 寧夏醫學雜志, 2005, 27(2):134.
24.	Brancusi F, Farrar J, Heemskerk D. Tuberculous meningitis in adults:a review of a decade of developments focusing on prognostic factors for outcome[J]. Future Microbiol, 2012, 7(9):1101-1116.

1. World Health Organization. Global tuberculosis control:surveillance, planning, financing. WHO report WHO/HTM/TB/2007.376[R]. Geneva:World Health Organization, 2007.
2. Zumla A, Raviglione M, Hafner R, et al. Tuberculosis[J]. N Engl J Med, 2013, 368(8):745-755.
3. Liao PW, Chiang TR, Lee MC, et al. Tuberculosis with meningitis, myeloradiculitis, arachnoiditis and hydrocephalus:a case report[J]. Acta Neurol Taiwan, 2010, 19(3):189-193.
4. Lienhardt C, Fielding K, Sillah JS, et al. Investigation of the risk factors for tuberculosis:a case-control study in three countries in West Africa[J]. Int J Epidemiol, 2005, 34(4):914-923.
5. Lienhardt C, Bennett S, Del Prete G, et al. Investigation of environmental and host-related risk factors for tuberculosis in Africa. I. Methodological aspects of a combined design[J]. Am J Epidemiol, 2002, 155(11):1066-1073.
6. Wright A. Anti-tuberculosis drug resistance in the world. Fourth Global Report:the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance[M]. 4th ed. Geneva:World Health Organization, 2008.
7. 閆世明, 孫秀娟, 鄒志艷, 等. 不同劑量地塞米松治療結核性腦膜炎的對比觀察[J]. 中華結核和呼吸雜志, 1995, 18(4):236.
8. 劉風霞, 劉雪云, 戰云飛. 結核性腦膜炎96例臨床分析[J]. 臨床肺科雜志, 2012, 17(3):471-472.
9. 中華醫學會. 臨床診療指南結核病學分冊[M]. 北京:人民衛生出版社, 2009:58-61.
10. 劉建民, 關玲, 侯紅革, 等. 結核性腦膜炎120例臨床分析[J]. 中國實用神經疾病雜志, 2012, 15(20):66-67.
11. 孫沖, 徐迪榮, 李碧磊. 改良Rankin量表在急性大面積腦梗死長期生存的預后價值[J]. 醫學研究雜志, 2012, 41(12):179-182.
12. World Health Organization. Global tuberculosis control 2009:epidemiology strategy financing[M]. http://reliefweb.int/sites/reliefweb.int/files/resources/878BDA5E2504C9F449257584001B5E60-who_mar2009.pdf.
13. 王黎霞. 中國耐多藥結核病的控制亟待加強[J]. 中華結核和呼吸雜志, 2009, 32(8):561-563.
14. 馬玙, 朱莉貞, 潘毓萱. 結核病[M]. 北京:人民衛生出版社, 2006:254-262.
15. Mizutani T, Kurosawa N, Matsuno Y, et al. A typical manifestation of tubeiculous meninpitis[J]. Eur Nenrol, 1993, 33(2):159-162.
16. 趙鋼, 杜芳. 結核性腦膜炎臨床診斷思路[J]. 中國現代神經疾病雜志, 2013, 13(1):1-4.
17. 張艷虹. 高原地區兒童結核性腦膜炎臨床特征及早期診斷探討[J]. 醫學綜述, 2011, 17(16):2552-2553.
18. 王郁. 結核性腦膜炎臨床診斷與治療分析——附48例報道[J]. 中國醫藥指南, 2011, 9(26):64-65.
19. Panicker JN, Nagaraja D, Subbakrishna DK, et al. Role of the BACTEC radiometric method in the evaluation of patients with clinically probable tuberculous meningitis[J]. Ann Indian Acad Neurol, 2010, 13(2):128-131.
20. 葉叔文, 王明杰, 鄒建勛, 等. 腦結核的CT及MR診斷[J]. 浙江中西醫結合雜志, 2012, 22(1):51-53.
21. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis[J]. Cochrane Database Syst Rev, 2008(1):CD002244.
22. Sinner SW, Tunkel AR. Approach to the diagnosis and management of tuberculous meningitis[J]. Curr Infect Dis Rep, 2002, 4(4):324-331.
23. 張魯軍, 劉麗, 趙巧華. 35例結核性腦膜炎臨床死亡原因分析[J]. 寧夏醫學雜志, 2005, 27(2):134.
24. Brancusi F, Farrar J, Heemskerk D. Tuberculous meningitis in adults:a review of a decade of developments focusing on prognostic factors for outcome[J]. Future Microbiol, 2012, 7(9):1101-1116.

Previous Article
Clinical Features of and Prognosis Factors for Spontaneous Intracranial Hypotension
Next Article
The Study on the Relationship between Daily Activity and Patent Foramen Ovale

West China Medical Journal

Analysis of the Curative Effect and Prognosis of 32 Cases of Drug Resistant Tuberculosis Meningitis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content